SHENZHEN, China & LOS ANGELES--(BUSINESS WIRE)--BioPharm Asia Inc. (OTCBB: BFAR - News), a rapidly growing pharmaceutical company in China, today announced that it is preparing its Annual Report on Form 10-K for the year ended December 31, 2009. This filing has been delayed due to the change in the Company’s auditors, which occurred in late February, and the recent appointment of Wenzhong Qin as its Chief Financial Officer, which occurred on March 23, 2010.
